These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10202904)

  • 1. Antibiotic resistance--to treat..
    Blower S; Koelle K; Lietman T
    Nat Med; 1999 Apr; 5(4):358. PubMed ID: 10202904
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study on tuberactinomycin, a new antibiotic].
    Osato T; Toyoara M
    Kekkaku; 1971 May; 46(3):59-63. PubMed ID: 4324041
    [No Abstract]   [Full Text] [Related]  

  • 3. Some healthy skepticism about inhaled therapy for tuberculosis.
    Iseman MD
    Clin Infect Dis; 2001 Jul; 33(2):266-7. PubMed ID: 11418891
    [No Abstract]   [Full Text] [Related]  

  • 4. Virulence attenuation and other biological modifications in multiple drug resistant tubercle mycobacteria.
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P; Serafini NA; Termine A; Zubiani M
    Boll Ist Sieroter Milan; 1971; 50(4):353-61. PubMed ID: 5005885
    [No Abstract]   [Full Text] [Related]  

  • 5. The fundamental studies on antituberculous activities of lividomycin.
    Gomi J; Aoyagi T; Torikai K; Yamada Y; Fujino T
    Kekkaku; 1971 Jul; 46(7):265-9. PubMed ID: 4329783
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antituberculous action of a new antibiotic, Lividomycin. Effect on experimental tuberculosis of mice and cross resistance with other antituberculous agents].
    Tsukamura M; Mizuno S; Yamamoto M
    Kekkaku; 1970 Aug; 45(8):263-72. PubMed ID: 4989999
    [No Abstract]   [Full Text] [Related]  

  • 7. [An experimental study on the antituberculous activity of tuberactiomycin-N].
    Toyoara M
    Kekkaku; 1972 Jun; 47(6):181-7. PubMed ID: 4628191
    [No Abstract]   [Full Text] [Related]  

  • 8. [Resistance pattern of Mycobacterium tuberculosis (H 37 Rv) to a new antibiotic, lividomycin].
    Tsukamura M; Mizuno S
    Kekkaku; 1972 Apr; 47(4):63-7. PubMed ID: 4627477
    [No Abstract]   [Full Text] [Related]  

  • 9. [Observations on the chemo-antibiotic-resistance in vitro of more than 400 strains of Mycobacterium tuberculosis recently isolated].
    Spaziante G; Caroli G; Mazzarone R
    Riv Ital Ig; 1966; 26(5):512-34. PubMed ID: 4967921
    [No Abstract]   [Full Text] [Related]  

  • 10. [Frequency of primary resistance of the Koch bacillus].
    Taranger J; Charpin J; Rocassera JP; Ohresser P; Boutin C; Gratecos LA
    Mars Med; 1967; 104(7):663-6. PubMed ID: 4975162
    [No Abstract]   [Full Text] [Related]  

  • 11. [The clinical importance of the drug resistance of Mycobacterium tuberculosis in the practice of controlling tuberculosis (a review of WHO data and of foreign leterature)].
    Khomenko AG
    Probl Tuberk; 1968; 46(3):72-8. PubMed ID: 4971318
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug resistance in tuberculosis.
    Gandhi SR
    J Indian Med Assoc; 1970 Apr; 54(8):360-4. PubMed ID: 4990132
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biological and clinico-therapeutic importance of resistance].
    Maccacaro GA
    G Ital Chemioter; 1966; 13(1):3-10. PubMed ID: 4967320
    [No Abstract]   [Full Text] [Related]  

  • 14. Further acquisition of drug-resistance in multidrug-resistant tuberculosis during chemotherapy.
    Toyota E; Sekiguchi J; Shimizu H; Fujino T; Otsuka Y; Yoshikura H; Kuratsuji T; Kirikae T; Kudo K
    Jpn J Infect Dis; 2004 Dec; 57(6):292-4. PubMed ID: 15623961
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the significance of drug resistance of the causal agent for the clinical aspects of tuberculosis].
    Slepova RI
    Lab Delo; 1965; 11():686-8. PubMed ID: 4163045
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chemo-antibiotic-resistance in vitro of "atypical" mycobacteria and Mycobacterium tuberculosis].
    Caroli G; Spaziante G; Mazzarone R
    Riv Ital Ig; 1966; 26(5):535-46. PubMed ID: 4967922
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on antituberculous activity of lividomycin in vitro].
    Horai Z; Shimizu K; Yamamoto K; Fujisawa Y; Yamashita K
    Kekkaku; 1971 Oct; 46(10):401-4. PubMed ID: 5004573
    [No Abstract]   [Full Text] [Related]  

  • 19. [Resistance to antituberculosis drug in France; data provided by the Azay-Mycobacteria network and the National Reference Center on Mycobacteria].
    Robert J; Veziris N;
    Med Mal Infect; 2008 Jun; 38 Suppl 2():S68-70. PubMed ID: 18598875
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular determinants of drug resistance in tuberculosis.
    Riska PF; Jacobs WR; Alland D
    Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S4-10. PubMed ID: 10688142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.